top
Home Page Brain Tumor Medical Database

Diagnosis and Evaluation


Contents



Astrocytic Tumors


Jun Chen, Shu-Lan Huang, Tao Li and Xi-Lan Chen
In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry
Neuroradiology. 2006 May;48(5):312-8. Epub 2006 Mar 22.
Abstract

Miyamoto J, Tatsuzawa K, Owada K, Kawabe T, Sasajima H, Mineura K
Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron emission tomography for the detection of malignancy of orbital tumors
Neurol Med Chir (Tokyo). 2008;48(11):495-9. Release Date: November 25, 2008
  Abstract |   Reprint |   Links |   Issue

Toshinari Misaki, Takaaki Beppu, Takashi Inoue, Kuniaki Ogasawara, Akira Ogawa, Hiroyuki Kabasawa
Use of fractional anisotropy value by diffusion tensor MRI for preoperative diagnosis of astrocytic tumors: case report
Journal of Neuro-Oncology, 70(3): 343-348, December 2004. (Abstract+)

Xiangsong Z, Weian C.
Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.
J Neurooncol. 2007 May;82(3):305-11. Epub 2006 Nov 22.
PMID: 17120157 [PubMed - indexed for MEDLINE]

Zhang K, Li C, Liu Y, Li L, Ma X, Meng X, Feng D
Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2
Neuroradiology. 2007 Nov;49(11):913-9. Epub 2007 Sep 1
 Abstract | Links | BL 7:8


Atyp. Teratoid/Rhabdoid T.


Warmuth-Metz M, Bison B, Dannemann-Stern E, Kortmann R, Rutkowski S, Pietsch T
CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system
Neuroradiology. 2008 May;50(5):447-52. Epub 2008 Mar 15
  Abstract |   Links |   Issue


Brainstem Gliomas


Panigrahy A, Nelson Jr MD, Finlay JL, Sposto R, Krieger MD, Gilles FH, Blüml S.
Metabolism of diffuse intrinsic brainstem gliomas in children.
Neuro Oncol. 2007 Nov 14; [Epub ahead of print]
Abstract | Links


Choroid Plexus Papilloma


D'Ambrosio AL, O'Toole JE, Connolly ES Jr, Feldstein NA
Villous hypertrophy versus choroid plexus papilloma: a case report demonstrating a diagnostic role for the proliferation index
Pediatr Neurosurg. 2003 Jul;39(2):91-6



CNS Lymphoma


Neuwelt EA, Guastadisegni PE, Varallyay P, Doolittle ND
Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery
AJNR Am J Neuroradiol. 2005 Feb;26(2):258-65

Soussain C, Muldoon LL, Varallyay C, Jahnke K, Depaula L, Neuwelt EA. 
Characterization and magnetic resonance imaging of a rat model of human B-cell central nervous system lymphoma.
Clin Cancer Res. 2007 Apr 15;13(8):2504-11.
PMID: 17438111 [PubMed - in process]


Taillibert S, Guillevin R, Menuel C, Sanson M, Hoang-Xuan K, Chiras J, Duffau H
Brain lymphoma: usefulness of the magnetic resonance spectroscopy
J Neurooncol. 2008 Jan;86(2):225-9. Epub 2007 Sep 4
 Abstract | Links | BL 7:6


Brain Tumors


Auer T, Schwarcz A, Janszky J, Horvath Z, Kosztolanyi P, Doczi T. 
Application of functional MR-images acquired at low field in planning of neurosurgical operation close to an eloquent brain area
Ideggyogy Sz. 2007 Jan 20;60(1-2):35-40. Hungarian.
PMID: 17432092 [PubMed - in process]

A Bizzi, U. Danesi, B. Pollo, L. Bissola, P. Ferroli, C. Solero, A. Boiardi, G. Broggi
H-MR Spectroscopic Imaging-guided Surgery of Brain Tumors and correlation with Neuropathology
Proc. Int. Symp. “New Treatments for Brain Tumors: Gene Therapy and Neural Stem Cells”, Parma, Italy, October 17-20, 2001,
Abstract No. O-1

William G. Bradley, MD, PhD
Achieving Gross Total Resection of Brain Tumors: Intraoperative MR Imaging Can Make a Big Difference
American Journal of Neuroradiology 23:348-349, March 2002. (PDF Full Text)

Broholm H, Rubin I, Kruse A, Braendstrup O, Schmidt K, Skriver EB, Lauritzen M
Nitric oxide synthase expression and enzymatic activity in human brain tumors
Clin Neuropathol. 2003 Nov-Dec;22(6):273-81


Brown GG, Clark C, Liu TT. 
Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications.
J Int Neuropsychol Soc. 2007 May;13(3):526-38.
PMID: 17445302 [PubMed - in process]

Clarke JL, Chang S
Pseudoprogression and pseudoresponse: challenges in brain tumor imaging
Curr Neurol Neurosci Rep. 2009 May;9(3):241-6
  Abstract |   Links |   Issue

Feldman SC, Chu D, Schulder M, Barry M, Cho ES, Liu WC
The blood oxygen level-dependent functional MR imaging signal can be used to identify brain tumors and distinguish them from normal tissue.
AJNR Am J Neuroradiol. 2009 Feb;30(2):389-95
  Abstract |   Links |   Issue

Galldiks N, Kracht LW, Berthold F, Miletic H, Klein JC, Herholz K, Jacobs AH, Heiss WD
[(11)C]-L: -Methionine positron emission tomography in the management of children and young adults with brain tumors
J Neurooncol. 2009 Jul 4. [Epub ahead of print]
  Abstract |   Full Text |   Reprint |   Links |   Issue

Geerts J, Martens M, Vandevenne JE, Gelin G, Grieten M, Weyns F, Stinissen P, Palmers Y, Wuyts J.
Functional magnetic resonance imaging for preoperative localisation of eloquent brain areas relative to brain tumours: clinical implementation in a regional hospital.
JBR-BTR. 2007 Jul-Aug;90(4):258-63.
  Abstract

Grosu AL, Lachner R, Wiedenmann N, Stark S, Thamm R, Kneschaurek P, Schwaiger M, Molls M, Weber WA
Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1450-63


Hall WA, Kim P, Truwit CL.
Functional magnetic resonance imaging-guided brain tumor resection
Top Magn Reson Imaging. 2009 Jan;19(4):205-12
  Abstract |   Links |   Issue

Hourani R, Brant LJ, Rizk T, Weingart JD, Barker PB, Horská A.
Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?
AJNR Am J Neuroradiol. 2008 Feb;29(2):366-72. Epub 2007 Nov 30
 Abstract |  Full Text |  Reprint | Links | BL 7:9

Jain R, Scarpace L, Ellika S, Schultz LR, Rock JP, Rosenblum ML, Patel SC, Lee TY, Mikkelsen T.
First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis.
Neurosurgery. 2007 Oct;61(4):778-86; discussion 786-7.
Abstract

Kajimoto K, Oku N, Kimura Y, Kato H, Tanaka MR, Kanai Y, Kitagawa K, Maruno M, Yoshimine T, Hori M, Hatazawa J.
Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
Ann Nucl Med. 2007 Feb;21(2):109-13.
PMID: 17424977 [PubMed - in process]

Kuhn MJ, Picozzi P, Maldjian JA, Schmalfuss IM, Maravilla KR, Bowen BC, Wippold FJ 2nd, Runge VM, Knopp MV, Wolansky LJ, Gustafsson L, Essig M, Anzalone N. 
Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
J Neurosurg. 2007 Apr;106(4):557-66.
PMID: 17432704 [PubMed - in process]

S. M. Kurian, E. B. Crowell
Concordance of FDG-PET scan and MRI- spectroscopy in primary and metastatic intracranial tumors
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1551


Li YD, Geng DY, Zhang QB, Jiang SH
Discrepancy between the dynamic computed tomography and t2* magnetic resonance perfusion imaging in brain tumors: a report of 2 cases
J Comput Assist Tomogr. 2007 Nov-Dec;31(6):896-900
Abstract | Links

Lucignani G.
Hints on new applications of emission tomography and magnetic resonance in neuro-oncology.
Eur J Nucl Med Mol Imaging. 2007 Jun 29; [Epub ahead of print] No abstract available.
PMID: 17604987 [PubMed - as supplied by publisher]

Madhusoodanan S, Danan D, Moise D.
Psychiatric manifestations of brain tumors: diagnostic implications.
Expert Rev Neurother. 2007 Apr;7(4):343-9.
PMID: 17425489 [PubMed - in process]

Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A, Baram J, Orenstein A, Cohen JS, Tichler T
Early Detection of Response to Radiation Therapy in Patients With Brain Malignancies Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance Imaging
J Clin Oncol 2003 Mar 15;21(6):1094-100 


Meyer PT, Schreckenberger M, Spetzger U, Meyer GF, Sabri O, Setani KS, Zeggel T, Buell U
Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses
Eur J Nucl Med. 2001 Feb;28(2):165-74


Nabavi A, Goebel S, Doerner L, Warneke N, Ulmer S, Mehdorn M.
Awake craniotomy and intraoperative magnetic resonance imaging: patient selection, preparation, and technique
Top Magn Reson Imaging. 2009 Jan;19(4):191-6
  Abstract |   Links |   Issue

E. A. Neuwelt, L. Konyves-Kolonics, M. Haluska
Ferumoxtran-10 enhanced MR in variety of intracranial tumors and other lesions
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 488

Jeffrey R. Petrella, MD, Lubdha M. Shah, MD, Katy M. Harris, BS, Allen H. Friedman, MD, Timothy M. George, MD, John H. Sampson, MD, PhD, Joseph S. Pekala, MD and James T. Voyvodic, PhD
Preoperative Functional MR Imaging Localization of Language and Motor Areas: Effect on Therapeutic Decision Making in Patients with Potentially Resectable Brain Tumors
Radiology 2006 (September) 240: 793-802. Published online before print July 20 2006, 10.1148/radiol.2403051153

Pirotte B, Goldman S, Salzberg S, Wikler D, David P, Vandesteene A, Van Bogaert P, Salmon I, Brotchi J, Levivier M
Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases
Pediatr Neurosurg 2003 Mar;38(3):146-55


Plesec TP, Prayson RA.
Frozen section discrepancy in the evaluation of central nervous system tumors.
Arch Pathol Lab Med. 2007 Oct;131(10):1532-40.
Full Text | Reprint

Prabhakar R, Haresh KP, Ganesh T, Joshi RC, Julka PK, Rath GK.
Comparison of computed tomography and magnetic resonance based target volume in brain tumors.
J Cancer Res Ther. 2007 Apr-Jun;3(2):121-3.
Full Text | Reprint | Links

Prins, Robert M. Ph.D.; Bruhn, Kevin W. Ph.D.; Craft, Noah M.D., Ph.D.; Lin, Jia Wei M.D.; Kim, Choong-Hyun M.D., Ph.D.; Odesa, Sylvia K. B.S.; Miller, Jeff F. Ph.D.; Liau, Linda M. M.D., Ph.D.
Central Nervous System Tumor Immunity Generated by a Recombinant Listeria monocytogenes Vaccine Targeting Tyrosinase Related Protein-2 and Real-Time Imaging of Intracranial Tumor Burden
Neurosurgery. 58(1):169-178, January 2006
Abstract

James M. Provenzale, MD, Srinivasan Mukundan, PhD, MD and Daniel P. Barboriak, MD
Diffusion-weighted and Perfusion MR Imaging for Brain Tumor Characterization and Assessment of Treatment Response
Radiology. 2006 Jun;239(3):632-49; DOI: 10.1148/radiol.2393042031
Abstract

Rueger MA, Kracht LW, Hilker R, Thiel A, Sobesky J, Winkeler A, Thomas AV, Heneka MT, Graf R, Herholz K, Heiss WD, Jacobs AH.
Role of in vivo imaging of the central nervous system for developing novel drugs.
Q J Nucl Med Mol Imaging. 2007 Jun;51(2):164-81.
PMID: 17420717 [PubMed - in process]

Saraswathy A, Jayasree RS, Baiju KV, Gupta AK, Pillai VP
Optimum Wavelength for the Differentiation of Brain Tumor Tissue Using Autofluorescence Spectroscopy
Photomed Laser Surg. 2008 Nov 23;. [Epub ahead of print]
  Abstract |   Links |   Issue

Schwindack C, Siminotto E, Meyer M, McNamara A, Marshall I, Wardlaw JM, Whittle IR
Real-time functional magnetic resonance imaging (rt-fMRI) in patients with brain tumours: preliminary findings using motor and language paradigms

Br J Neurosurg. 2005 Feb;19(1):25-32

Talbot JN, Kerrou K, Montravers F, Nataf V, Chevalme Y. 
FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines.
Eur J Nucl Med Mol Imaging. 2007 Apr 17; [Epub ahead of print] No abstract available.
PMID: 17437107 [PubMed - as supplied by publisher]

Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K
Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy
J Nucl Med. 2008 Apr 15; [Epub ahead of print]
 Abstract |  Links | BL 7:9

Katherine E. Warren
NMR Spectroscopy and Pediatric Brain Tumors 
The Oncologist, Vol. 9, No. 3, 312–318, June 2004. (PDF Full Text) 


Young GS.
Advanced MRI of adult brain tumors.
Neurol Clin. 2007 Nov;25(4):947-73.
Abstract

Zamboni SL, Loenneker T, Boltshauser E, Martin E, Il'yasov KA.
Contribution of Diffusion Tensor MR Imaging in Detecting Cerebral Microstructural Changes in Adults with Neurofibromatosis Type 1.
AJNR Am J Neuroradiol. 2007 Apr;28(4):773-6.
PMID: 17416837 [PubMed - in process]


Diffuse Astrocytoma


Bela Bodey, Vivian Bodey, Stuart E. Siegel, Hans E. Kaiser
Mage-1, a cancer-testis antigen, and p53 expression in childhood astrocytomas as an indicator of tumor progression
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 158

Ehrenfeld CE, Maschke M, Dörfler A, Reinhardt V, Koeppen S
Is stereotactic biopsy a reliable method to differentiate tumor from radiation necrosis?
Clin Neuropathol 2002 Jan-Feb;21(1):9-12
 Abstract |
Links | BL 1:3

Schlemmer HP, Bachert P, Henze M, Buslei R, Herfarth KK, Debus J, van KG
Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy
Neuroradiology 2002 Mar;44(3):216-22


Edema


Kimura T, Ohkubo M, Igarashi H, Kwee IL, Nakada T. 
Increase in glutamate as a sensitive indicator of extracellular matrix integrity in peritumoral edema: a 3.0-tesla proton magnetic resonance spectroscopy study.
J Neurosurg. 2007 Apr;106(4):609-13.
PMID: 17432711 [PubMed - in process]


Enhancement


Kamel MH, Kelleher M, O'riordan C, Keohane C, O'sullivan M.
CT and MRI 'ring sign' may be due to demyelination: diagnostic pitfall.
Br J Neurosurg. 2007 Jun;21(3):309-11.
PMID: 17612927 [PubMed - in process]


Glioblastoma


Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts DC, Giangaspero F
Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme
J Neurosurg. 1983 Feb; 58(2): 159-69

Colavolpe C, Guedj E, Metellus P, Barrie M, Figarella-Branger D, Mundler O, Chinot O
FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report
J Neurooncol. 2008 Jun 21; [Epub ahead of print]
 Abstract | Links | BL 7:13

Crawford FW, Khayal IS, McGue C, Saraswathy S, Pirzkall A, Cha S, Lamborn KR, Chang SM, Berger MS, Nelson SJ.
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
J Neurooncol. 2008 Nov 15; [Epub ahead of print]
  Abstract |   Links |   Issue

Hochberg FH, Pruitt A
Assumptions in the radiotherapy of glioblastoma
Neurology. 1980 Sep; 30(9): 907-11

Jung CS, Foerch C, Schänzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe A, Sitzer M.
Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Brain. 2007 Nov 12; [Epub ahead of print]
Abstract | Links

Samira Guccione, Yishan Yang, Ron Homer, Steven Chang, Griff Harsh, Scott Atlas, Mark Bednarski
The use of MRI in patients with glioblastoma multiforme to identify regions of vascular permeability for genomic analysis
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2958

Kleinberg L, Yoon G, Weingart JD, Parisi M, Olivi A, Detorie NA, Chan TA
Imaging After GliaSite Brachytherapy: Prognostic MRI Indicators of Disease Control and Recurrence
Int J Radiat Oncol Biol Phys. 2009 Apr 23;. [Epub ahead of print]
  Abstract |   Links |   Issue

Laprie A, Catalaa I, Cassol E, McKnight TR, Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study
Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):773-81; Epub 2008 Feb 6
 Abstract | Links | BL 7:4

Mukundan S, Holder C, Olson JJ.
Neuroradiological assessment of newly diagnosed glioblastoma
J Neurooncol. 2008 Sep;89(3):259-69. Epub 2008 Aug 20
 Abstract | Links |   BL 7:17

Principi M, Italiani M, Guiducci A, Aprile I, Muti M, Giulianelli G, Ottaviano P
Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas
Neuroradiology 2003 Apr;45(4):205-11

Sanal HT, Bulakbasi N, Kocaoglu M, Onguru O, Chen L.
Giant Infantile Gliosarcoma: Magnetic Resonance Imaging Findings
J Child Neurol. 2008 Apr 10; [Epub ahead of print]
 Abstract |  Reprint | Links | BL 7:8

Saraswathy S, Crawford FW, Lamborn KR, Pirzkall A, Chang S, Cha S, Nelson SJ.
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
J Neurooncol. 2008 Sep 23; [Epub ahead of print]
  Abstract |   Links |   BL 7:19

Shaan M. Raza, B.S.; Frederick F. Lang, M.D.; Bharat B. Aggarwal, Ph.D.; Gregory N. Fuller, Ph.D., M.D.; David M. Wildrick, Ph.D.; Raymond Sawaya,M.D.
Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis
Neurosurgery. 51(1):2-13, July 2002
Abstract | Links | BL 1:1

Spence AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC, Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA
Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival
Clin Cancer Res. 2008 May 1;14(9):2623-30
 Abstract | Links | BL 7:10

Kevin S. Tralins, MD, James G. Douglas, MD, MS, Keith J. Stelzer, MD, PhD, David A. Mankoff, MD, Daniel L. Silbergeld, MD, Robert Rostomilly, MD, Sharon Hummel, MS, Jeff Scharnhorst, BS, Kenneth A. Krohn, PhD and Alexander M. Spence, MD
Volumetric Analysis of 18F-FDG PET in Glioblastoma Multiforme: Prognostic Information and Possible Role in Definition of Target Volumes in Radiation Dose Escalation
Journal of Nuclear Medicine Vol. 43 No. 12 1667-1673


Saxena V, Gonzalez-Gomez I, Laug WE.
A Non-invasive, In Vivo Technique for Monitoring Vascular Status of Glioblastoma During Angiogenesis.
Technol Cancer Res Treat. 2007 Dec;6(6):641-50.
Abstract | Links

Swanson KR, Chakraborty G, Wang CH, Rockne R, Harpold HL, Muzi M, Adamsen TC, Krohn KA, Spence AM
Complementary but Distinct Roles for MRI and 18F-Fluoromisonidazole PET in the Assessment of Human Glioblastomas
J Nucl Med. 2008 Dec 17; [Epub ahead of print]
  Abstract |   Links |   Issue

Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG
Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
Int J Radiat Oncol Biol Phys. 1989 Jun; 16(6): 1405-9

Zhang R, Tremblay TL, McDermid A, Thibault P, Stanimirovic D
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors
Glia 2003 Apr 15;42(2):194-208


Gliomas


Atkinson M, Juhasz C, Shah J, Guo X, Kupsky W, Fuerst D, Johnson R, Watson C
Paradoxical imaging findings in cerebral gliomas
J Neurol Sci. 2008 Feb 5; [Epub ahead of print]
Abstract | Links | BL 7:4

Brekke C, Williams SC, Price J, Thorsen F, Modo M.
Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model.
Neuroimage. 2007 Jun 14; [Epub ahead of print]
PMID: 17613248 [PubMed - as supplied by publisher]

Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken R, Ross BD, Chenevert TL, Lawrence TS
Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT
Int J Radiat Oncol Biol Phys. 2005 Nov 17; [Epub ahead of print]

de Witt MC, de Bruin HG, Ejkenboom W, Sillevis Smitt PAE and van den Bent
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression
Neurology 63:535-537, 2004 Aug 10
Abstract |  Full Text |   Reprint | Links

De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I, Brotchi J, Goldman S
Positron emission tomography with injection of methionine as a prognostic factor in glioma

J Neurosurg. 2001 Nov;95(5):746-50

E. Galanis, M. J. Maurer, K. V. Ballman, J. O'Fallon, R. Sykora, R. Castillo, J. C. Buckner, B. J. Erickson
Validation of neuroradiologic response assessment in gliomas: RECIST (1D) vs 2D measurements vs computer-assisted tumor area vs volume
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 423

Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S
High-grade and low-grade gliomas: differentiation by using perfusion MR imaging
Clin Radiol. 2005 Apr;60(4):493-502

Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T.
Metabolic Assessment of Gliomas Using 11C-Methionine, [18F] Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography
AJNR Am J Neuroradiol. 2008 Apr 3; [Epub ahead of print]
 Abstract | Links | BL 7:8

Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB
Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms
Mayo Clin Proc. 1987 Jun; 62(6): 450-9

Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L
A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation
Cancer Res. 2003 Dec 1;63(23):8122-5


Konukoglu E, Clatz O, Bondiau PY, Delingette H, Ayache N.
Extrapolating glioma invasion margin in brain magnetic resonance images: Suggesting new irradiation margins
Med Image Anal. 2009 Dec 3;. [Epub ahead of print]
  Abstract |   Links |   CNO 9(2)

Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment
Radiology. 2000 Nov;217(2):377-84
  Abstract |   Full Text |   Reprint | Links

Kuznetsov YE, Caramanos Z, Antel SB, Preul MC, Leblanc R, Villemure JG, Pokrupa R, Olivier A, Sadikot A, Arnold DL
Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas
Neurosurgery. 2003 Sep;53(3):565-76  

Leach PA, Estlin EJ, Coope DJ, Thorne JA, Kamaly-Asl ID
Diffuse brainstem gliomas in children: should we or shouldn't we biopsy?
Br J Neurosurg. 2008 Oct;22(5):619-24
  Abstract |   Links |   Issue

Lichy MP, Bachert P, Henze M, Lichy CM, Debus J, Schlemmer HP
Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy
Neuroradiology. 2003 Dec 18 [Epub ahead of print].


Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC, Golfinos JG, Zagzag D, Johnson G.
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging
Radiology. 2008 May;247(2):490-8. Epub 2008 Mar 18
 Abstract |  News | Links | BL 7:10

Lu H, Pollack E, Young R, Babb JS, Johnson G, Zagzag D, Carson R, Jensen JH, Helpern JA, Law M.
Predicting Grade of Cerebral Glioma Using Vascular-Space Occupancy MR Imaging.
AJNR Am J Neuroradiol. 2007 Nov 1; [Epub ahead of print]
Abstract

Majós C, Aguilera C, Alonso J, Julià-Sapé M, Castañer S, Sánchez JJ, Samitier A, León A, Rovira A, Arús C
Proton MR Spectroscopy Improves Discrimination between Tumor and Pseudotumoral Lesion in Solid Brain Masses
AJNR Am J Neuroradiol. 2008 Dec 18; [Epub ahead of print]
  Abstract |   Reprint |   Links |   Issue

Yael Mardor, Roberto Spiegelmann, Yiftach Roth, Arie Orenstein, Stephan E. Maier, Ouzi Nissim, Zvi Ram, Jacob Baram, Thomas Tichler, Raphael Pfeffer
Pre-treatment prediction of brain tumor response to radiation therapy using high diffusion-weighted MRI
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2547

Murphy PS, Viviers L, Abson C, Rowland IJ, Brada M, Leach MO, Dzik-Jurasz AS
Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy
Br J Cancer. 2004 Feb 23;90(4):781-6

M.V. Padma, S. Said, M. Jacobs, D.R. Hwang, K. Dunigan, M. Satter, B. Christian, J. Ruppert, T. Bernstein, G. Kraus, J.C. Mantil
Prediction of Pathology and Survival by FDG PET in Gliomas
Journal of Neuro-Oncology, 64 (3): 227-237, September 2003 

Susan Pannullo, D. C Shungu, R. L DeLaPaz, M. Odaimi, J. Serventi, L. Heller, C. M Balmaceda
Use of magnetic resonance spectroscopy (MRS) in malignant gliomas treated with temozolomide (TMZ)
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
2101

Michail Plotkin, Julia Eisenacher, Harald Bruhn, Reinhard Wurm, Roger Michel, Florian Stockhammer, Annelie Feußner, Oliver Dudeck, Peter Wust, Roland Felix, Holger Amthauer
123I-IMT SPECT and 1HMR-Spectroscopy at 3.0T in the Differential Diagnosis of Recurrent or Residual Gliomas: A Comparative Study
J Neurooncol, 70 (1):49-58, Oct. 2004. (Abstract+)

Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA
How often are nonenhancing supratentorial gliomas malignant? A population study
Neurology. 2002 Sep 24;59(6):947-9


Schaller BJ, Cornelius JF, Sandu N, Buchfelder M.
Molecular imaging of brain tumors personal experience and review of the literature
Curr Mol Med. 2008 Dec;8(8):711-26
  Abstract |   Links |   Issue

Takahashi Y, Imahori Y, Mineura K
Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas
Clin Cancer Res. 2003 Dec 1;9(16):5888-95

Tanwar MK, Gilbert MR, Holland EC.
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma
Cancer Res 2002 Aug 1;62(15):4364-8
 Abstract |  Full Text |  Reprint |
Links | BL 1:2

Vos MJ, Uitdehaag BM, Barkhof F, Heimans JJ, Baayen HC, Boogerd W, Castelijns JA, Elkhuizen PH, Postma TJ
Interobserver variability in the radiological assessment of response to chemotherapy in glioma
Neurology 2003 Mar 11;60(5):826-30



Gliomas (High-Grade)


Brat DJ, Prayson RA, Ryken TC, Olson JJ.
Diagnosis of malignant glioma: role of neuropathology
J Neurooncol. 2008 Sep;89(3):287-311. Epub 2008 Aug 20
 Abstract | Links |   BL 7:17

Burnet NG, Lynch AG, Jefferies SJ, Price SJ, Jones PH, Antoun NM, Xuereb JH, Pohl U.
High grade glioma: Imaging combined with pathological grade defines management and predicts prognosis
Radiother Oncol. 2007 Nov 26; [Epub ahead of print]
Abstract | Links

Gonzalez-Bonet LG.
Stereotactic biopsy versus spectroscopy in cases of gliomas with a high degree of malignancy. A review of the literature
Rev Neurol. 2008 Sep 16-30;47(6):310-4. Spanish
 Abstract |  Reprint | Links |  BL 7:20

Adília Hormigo, Bin Gu, Sasan Karimi, Elyn Riedel, Katherine S. Panageas, Mark A. Edgar, Meena K. Tanwar, Jasti S. Rao, Martin Fleisher, Lisa M. DeAngelis and Eric C. Holland
YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas
Clin Cancer Res. 2006 Oct 1;12(19):5698-704.

Pirotte BJ, Levivier M, Goldman S, Massager N, Wikler D, Dewitte O, Bruneau M, Rorive S, David P, Brotchi J
Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients
Neurosurgery. 2009 Mar;64(3):471-81
  Abstract |    Links |   Issue

Prat R, Galeano I, Lucas A, Martínez JC, Martín M, Amador R, Reynés G.
Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-((18)F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas
J Clin Neurosci. 2009 Dec 1. [Epub ahead of print]
  Abstract | Links |   CNO 9(1)

Sankar T, Caramanos Z, Assina R, Villemure JG, Leblanc R, Langleben A, Arnold DL, Preul MC
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma
J Neurooncol. 2008 Jul 4. [Epub ahead of print]
 Abstract |
Links | BL 7:14

Shirahata M, Iwao-Koizumi K, Saito S, Ueno N, Oda M, Hashimoto N, Takahashi JA, Kato K
Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis
Clin Cancer Res. 2007 Dec 15;13(24):7341-56

Abstract | Links

V. Vallejos, C. BalañM. Fraile, Y. Roussos, J. Capellades, P. Cuadras, R. Ballester, A. Ley, A. Arellano, R. Rosell
Use of 201Tl SPECT Imaging to Assess the Response to Therapy in Patients with High Grade Gliomas
Journal of Neuro-Oncology, 59 (1): 81-90, August 2002
 Abstract |  Reprint |  Links | BL 1:3


Gliomas (Low-Grade)


Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR
Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
Radiology. 2008 Apr;247(1):170-8.
 Abstract |  News
| Links | BL 7:8

De Witte O, Oulad Ben Taib N, Branle F, Rorive S, Brotchi J, Goldman S
Contribution of PET to the management of patients with low-grade glioma
Neurochirurgie. 2004 Sep;50(4):468-73

Einar Goebell, MD, Susanne Paustenbach, Ole Vaeterlein, MD, Xiao-Qi Ding, PhD, MD, Oliver Heese, MD, Jens Fiehler, MD, Thomas Kucinski, MD, Christian Hagel, MD, Manfred Westphal, MD and Hermann Zeumer, MD
Low-Grade and Anaplastic Gliomas: Differences in Architecture Evaluated with Diffusion-Tensor MR Imaging
Radiology, 2006;239:217-222;
Published online before print February 16, 2006; DOI: 10.1148/radiol.2383050059
Abstract

Guillevin R, Menuel C, Duffau H, Kujas M, Capelle L, Aubert A, Taillibert S, Idbaih A, Pallud J, Demarco G, Costalat R, Hoang-Xuan K, Chiras J, Vallée JN
Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas
J Neurooncol. 2007 Dec 28; [Epub ahead of print]
Abstract | Links | BL 7:3

Gupta R, Mohindra S, Gupta K
Demyelination or low-grade glioma? A diagnostic dilemma
Surg Neurol. 2008 Feb 22; [Epub ahead of print]
 Abstract | Links | BL 7:6

Hattingen E, Raab P, Franz K, Lanfermann H, Setzer M, Gerlach R, Zanella FE, Pilatus U
Prognostic value of choline and creatine in WHO grade II gliomas
Neuroradiology. 2008 Jun 4. [Epub ahead of print]
 Abstract |  Full Text |  Reprint | Links | BL 7:12

Marcus Henze, MD, Ashour Mohammed, PhD, Heinz P. Schlemmer, MD, Klaus K. Herfarth, MD, Simone Hoffner, MD, Sabine Haufe, MD, Walter Mier, PhD, Michael Eisenhut, PhD, Jürgen Debus, MD, PhD and Uwe Haberkorn, MD
PET and SPECT for Detection of Tumor Progression in Irradiated Low-Grade Astrocytoma: A Receiver-Operating-Characteristic Analysis
Journal of Nuclear Medicine, April 1 2004, Volume 45, Issue 4, Pages 579-586

Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, Mendoza G, Weber-Luxenburger G, Lottgen J, Thiel A, Wienhard K, Heiss WD
11C-methionine PET for differential diagnosis of low-grade gliomas
Neurology. 1998 May;50(5):1316-22

Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu P, Van Effenterre R, Alvord EC Jr, Capelle L
Continuous growth of mean tumor diameter in a subset of grade II gliomas

Ann Neurol. 2003 Apr;53(4):524-8

Law, Meng M.D.; Oh, Sarah M.D.; Johnson, Glyn Ph.D.; Babb, James S. Ph.D.; Zagzag, David M.D., Ph.D.; Golfinos, John M.D.; Kelly, Patrick J. M.D.
Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an Adjunct to Histopathology: A Second Reference Standard in the Surgical and Nonsurgical Treatment of Low-grade Gliomas
Neurosurgery. 58(6):1099-1107, June 2006
Abstract | Full Text | Reprint

Lee EJ, Lee SK, Agid R, Bae JM, Keller A, Terbrugge K
Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient
AJNR Am J Neuroradiol. 2008 Nov;29(10):1872-7. Epub 2008 Aug 21
  Abstract |   Links |   Issue

Novak L, Molnar P, Lengyel Z, Tron L
Does increased 18FDG uptake reflect malignant transformation of a low-grade glioma? A diagnostic dilemma
Neurol India. 2005 Mar;53(1):112-4. (PDF Full Text)

Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E, Norrgard S, Kulmala J, Teras M, Minn H
Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52

Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D, Taillandier L, Capelle L.
Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas.
Ann Neurol. 2006 Sep 18;60(3):380-383 [Epub ahead of print]
Abstract

Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ, Wara WW, Larson DA, Sneed PK
Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy

Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1254-64

Ribom D, Larsson A, Pietras K, Smits A
Growth factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable
Neurol Sci. 2003 Jun;24(2):70-3

Ribom D, Westman-Brinkmalm A, Smits A, Davidsson P
Elevated levels of alpha-2-Heremans-Schmid glycoprotein in CSF of patients with low-grade gliomas

Tumour Biol. 2003 Mar-Apr;24(2):94-9

Ribom D, Engler H, Blomquist E, Smits A
Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas
Eur J Nucl Med Mol Imaging. 2002 May;29(5):632-40. Epub 2002 Mar 5

Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, Bolander H, Bergstrom M, Smits A
Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas
Cancer. 2001 Sep 15;92(6):1541-9

Seiz M, Dimitrakopoulou-Strauss A, Schubert GA, Weinmann C, Strauss LG, Eisenhut M, Tuettenberg J.
Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomas
Hell J Nucl Med. 2008 Sep-Dec;11(3):149-52
  Abstract |   Links |   Issue

Walker C, du Plessis DG, Fildes D, Haylock B, Husband D, Jenkinson MD, Joyce KA, Broome J, Kopitski K, Prosser J, Smith T, Vinjamuri S, Warnke PC
Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component
Clin Cancer Res. 2004 Nov 1;10(21):7182-91

Wyss M, Hofer S, Bruehlmeier M, Hefti M, Uhlmann C, Bärtschi E, Buettner UW, Roelcke U
Early metabolic responses in temozolomide treated low-grade glioma patients
J Neurooncol. 2009 Apr 18. [Epub ahead of print]
  Abstract |   Links |   Issue


Gliomatosis Cerebri


Galanaud D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M, Ranjeva JP, Fuentes S, Viout P, Figarella-Branger D, Cozzone PJ
Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma
J Neurosurg 2003 Feb;98(2):269-76



Intracerebral Hematoma


Minutoli F, Angileri FF, Cosentino S, Pecorella GR, Cardali S, De Divitiis O, Germano A, Baldari S
99mTc-MIBI SPECT in distinguishing neoplastic from nonneoplastic intracerebral hematoma
J Nucl Med. 2003 Oct;44(10):1566-73



Markers


Edward R. Smith, MD; David Zurakowski, PhD; Ali Saad, MD; R. Michael Scott, MD; Marsha A. Moses, PhD
Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy
American Association of Neurological Surgeons 76th Annual Meeting: Abstract 629. Presented April 28, 2008
 Abstract |  News |
Links | BL 7:10

Wakabayashi T, Natsume A, Hatano H, Fujii M, Shimato S, Ito M, Ohno M, Ito S, Ogura M, Yoshida J
p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas
Neurosurgery. 2009 Mar;64(3):455-61
  Abstract | Links |   Issue


Medulloepithelioma


Rajan Syal, Jaypal Reddy S, Raj Kumar, Isha Tyagi, A.A. Wani Abrar, Narender Krishnani, Asht M. Mishra, Rakesh K. Gupta
Unusual Clinical and MRI Features of a Cerebellopontine Angle Medulloepithelioma
Pediatr Neurosurg. 2006 Aug;42(5):299-303
Abstract


Medulloblastoma


CM Coffin, JT Braun, MR Wick and LP Dehner
A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression
Modern Pathology, 1990, Vol 3, Issue 2, 164-170 (
Laboratory Investigation, Abstract)

Yuksel M, Lutterbey G, Biersack HJ, Elke U, Hasan C, Gao Z, Bode U, Ezziddin S. 
111In-pentetreotide scintigraphy in medulloblastoma: a comparison with magnetic resonance imaging.
Acta Oncol. 2007;46(1):111-7.
PMID: 17438713 [PubMed - in process]



Meningioma


Ahmed SN, Scozzafava J.
Images in clinical medicine. Meningioma.
N Engl J Med. 2007 Apr 19;356(16):e14. No abstract available.
PMID: 17442901 [PubMed - indexed for MEDLINE]


Henze M, Dimitrakopoulou-Strauss A, Milker-Zabel S, Schuhmacher J, Strauss LG, Doll J, Macke HR, Eisenhut M, Debus J, Haberkorn U
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-Octreotide Kinetics in Patients with Meningiomas
J Nucl Med. 2005 May;46(5):763-9.

Owen CM, Schaller C, Binder DK.
The madness of Dionysus: a neurosurgical perspective on Friedrich Nietzsche.
Neurosurgery. 2007 Sep;61(3):626-31; discussion 631-2.
Full Text | Reprint

Stenzel W, Rohn G, Miletic H, Radner H, Deckert M, Ernestus RI.
Diagnostic impact of ornithine decarboxylase in meningiomas
J Neurooncol. 2004 Jan;66(1-2):59-64.


Zhang H, Rödiger LA, Shen T, Miao J, Oudkerk M
Perfusion MR imaging for differentiation of benign and malignant meningiomas
Neuroradiology. 2008 Apr 1; [Epub ahead of print]
 Abstract |  Full Text |  Reprint | Links | BL 7:8


Metastatic Tumors


Dieta Brandsma, Martin J.B. Taphoorn, Jaap C. Reijneveld, Thomas M. Nas, Emile E. Voest, Klaas Nicolay, Erwin Blezer
MR Imaging of Mouse Leptomeningeal Metastases
Journal of Neuro-Oncology,
68
(2): 123-130, June 2004. (Abstract+)

Chamberlain MC, Glantz M, Groves MD, Wilson WH
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment
Semin Oncol. 2009 Aug;36(4 Suppl 2):S35-45

  Abstract |   Full Text |   Reprint |  
Links |   CNO 8(10)

Dequesada IM, Quisling RG, Yachnis A, Friedman WA
Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study
Neurosurgery. 2008 Nov;63(5):898-903
  Abstract |   Links |   Issue

Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, Winkler F.
Real-time imaging reveals the single steps of brain metastasis formation
Nat Med. 2010 Jan;16(1):116-22
  Abstract |   Links |   CNO 9(2)

Kimura T, Sako K, Tanaka K, Gotoh T, Yoshida H, Aburano T, Tanaka T, Arai H, Nakada T
Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging
J Neurosurg. 2004 May;100(5):835-41


Lee HY, Lee KS, Kim BT, Cho YS, Lee EJ, Yi CA, Chung MJ, Kim TS, Kwon OJ, Kim H.
Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma
J Korean Med Sci. 2009 Dec;24(6):1132-8
  Abstract |   Full Text |   Reprint | Links |   CNO 9(1)

Seute T, Leffers P, Ten Velde GP, Twijnstra A.
Detection of brain metastases from small cell lung cancer : consequences of changing imaging techniques (CT versus MRI)
Cancer. 2008 Feb 29; [Epub ahead of print]
 Abstract | Links | BL 7:6


Neuroblastoma


Pearl GS, Takei Y
Cerebellar "neuroblastoma": nosology as it relates to medulloblastoma
Cancer. 1981 Feb 15;47(4):772-9


M Lindskog, P Kogner, F Ponthan, P Schweinhardt, B Sandstedt, T Heiden, G Helms and C Spenger
Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS)
British Journal of Cancer, 88: 478 - 485, 10 Feb 2003


N & Mixed N-Glial Tumors


Meyer PT, Spetzger U, Mueller HD, Zeggel T, Sabri O, Schreckenberger M
High F-18 FDG uptake in a low-grade supratentorial ganglioma: a positron emission tomography case report
Clin Nucl Med. 2000 Sep;25(9):694-7



Non-CNS Neoplasms


Yaron Hassid, Edna Furman-Haran, Raanan Margalit, Raya Eilam and Hadassa Degani
Noninvasive Magnetic Resonance Imaging of Transport and Interstitial Fluid Pressure in Ectopic Human Lung Tumors
Cancer Research, 66, 4159-4166, April 15, 2006
Abstract | News

Goodwin DA, Meares CF, McCall MJ, McTigue M, Chaovapong W
Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens
J Nucl Med. 1988 Feb; 29(2): 226-34


Hormigo A, Liberato B, Lis E, DeAngelis LM
Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities
Arch Neurol. 2004 Mar;61(3):362-5. (Retrospective Study, Abstract)


Jun Liu, Andrea L Levine, John S Mattoon, Mamoru Yamaguchi, Robert J Lee, Xueliang Pan and Thomas J Rosol
Nanoparticles as image enhancing agents for ultrasonography
Phys. Med. Biol., 2006 May 7;51(9):2179-89; Epub 2006 Apr 10; doi:10.1088/0031-9155/51/9/004
Abstract | News


Oligodendroglioma


F. Giammarile, L.E. Cinotti, A. Jouvet, J.M. Ramackers, G. Saint Pierre, P. Thiesse, E. Jouanneau, J. Guyotat, I. Pelissou-Guyotat, A. Setiey, J. Honnorat, D. Le Bars, D. Frappaz
High and Low Grade Oligodendrogliomas (ODG): Correlation of Amino-Acid and Glucose Uptakes Using PET and Histological Classifications
Journal of Neuro-Oncology,
68
(3): 263-274, July 2004. (Abstract+)

Hunt JL
Molecular testing in solid tumors: an overview
Arch Pathol Lab Med. 2008 Feb;132(2):164-7
 Abstract |  Full Text |  Reprint | Links | BL 7:6

Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, Criniere E, Capelle L, Duffau H, Cornu P, Broet P, Kujas M, Mokhtari K, Carpentier A, Sanson M, Hoang-Xuan K, Thillet J, Delattre JY
Correlations between molecular profile and radiologic pattern in oligodendroglial tumors

Neurology. 2004 Dec 28;63(12):2360-2


Pediatric Brain Tumors


Dorner L, Fritsch MJ, Stark AM, Mehdorn HM.
Posterior fossa tumors in children: how long does it take to establish the diagnosis?
Childs Nerv Syst. 2007 Apr 12; [Epub ahead of print]
PMID: 17429658 [PubMed - as supplied by publisher]

Duffner PK.
Diagnosis of brain tumors in children.
Expert Rev Neurother. 2007 Jul;7(7):875-85.
PMID: 17610394 [PubMed - in process]

A A. Tzika, Loukas G. Astrakas, David Zurakowski, Maria K. Zarifi, Tina P. Young, Liliana Goumnerova, Douglas C. Anthony, Mark Kieran, Nancy J. Tarbell, Peter M. Black
Predicting progression in children with pediatric brain tumors using magnetic resonance neuroimaging
Proceedings of the AACR, Volume 44, 1st ed., March 2003, Abstract No. 3411


Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):20-31

Porto L, Hattingen E, Pilatus U, Kieslich M, Yan B, Schwabe D, Zanella FE, Lanfermann H.
Proton magnetic resonance spectroscopy in childhood brainstem lesions.
Childs Nerv Syst. 2007 Mar;23(3):305-14. Epub 2006 Sep 16.
Full Text | Reprint

Poussaint TY, Phillips PC, Vajapeyam S, Fahey FH, Robertson RL, Osganian S, Ramamurthy U, Mulkern RV, Treves ST, Boyett JM, Kun LE.
The neuroimaging center of the pediatric brain tumor consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress.
AJNR Am J Neuroradiol. 2007 Apr;28(4):603-7.
PMID: 17416804 [PubMed - in process]

Samdani A, Jallo GI.
Intraoperative MRI: Technology, Systems, and Application to Pediatric Brain Tumors.
Surg Technol Int. 2007;16:236-43.
PMID: 17429795 [PubMed - in process]


Pilomyxoid Astrocytoma


Komotar RJ, Zacharia BE, Sughrue ME, Mocco J, Carson BS, Tihan T, Otten ML, Burger PC, Garvin JH, Khandji AG, Anderson RC
Magnetic resonance imaging characteristics of pilomyxoid astrocytoma
Neurol Res. 2008 Nov;30(9):945-51. Epub 2008 Jul 25
  Abstract |   Links |   Issue


Pleom. Xanthoastrocytoma


Crespo-Rodriguez AM, Smirniotopoulos JG, Rushing EJ.
MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature.
Neuroradiology. 2007 Apr;49(4):307-15. Epub 2007 Jan 5. Review.
PMID: 17205313 [PubMed - indexed for MEDLINE]


Proliferation


Kremer S, Pinel S, Vedrine PO, Bressenot A, Robert P, Bracard S, Plenat F. 
Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?
J Neurooncol. 2007 Apr 19; [Epub ahead of print]
PMID: 17443290 [PubMed - as supplied by publisher]



Rhabdomyosarcoma


Zhong J, Li ST, Yao XH, Jin B, Wan L
An intrasellar rhabdomyosarcoma misdiagnosed as pituitary adenoma
Surg Neurol. 2007 Dec; 68 Suppl 2:S29-33
 Abstract |  Links | BL 7:4


Schwannoma


Colosimo C, Cerase A, Denaro L, Maira G, Greco R
Magnetic resonance imaging of intramedullary spinal cord schwannomas. Report of two cases and review of the literature
J Neurosurg. 2003 Jul;99(1 Suppl):114-7



Spinal Cord Tumors


Jo M. Wilmshurst, Sally F. Barrington, Dylan Pritchard, Tim Cox, Peter Bullock, Michael Maisey, and Richard O. Robinson
Positron Emission Tomography in Imaging Spinal Cord Tumors
Journal of Child Neurology, Jul 2000; vol. 15: pp. 465 - 472
 Abstract |  Reprint | Links | BL 7:8


SPNET


VE Gould, DS Jansson, WM Molenaar, LB Rorke, JQ Trojanowski, VM Lee, RJ Packer and WW Franke
Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins
Lab Invest. 1990 Apr;62(4):498-509



Therapy Monitoring


Lindquist D.
Science to Practice: Is there a role for MR imaging in monitoring gene therapy response?
Radiology. 2007 Jun;243(3):611-2. No abstract available.
PMID: 17517921 [PubMed - indexed for MEDLINE]

Reif R, Wang M, Joshi S, A'amar O, Bigio IJ.
Optical method for real-time monitoring of drug concentrations facilitates the development of novel methods for drug delivery to brain tissue.
J Biomed Opt. 2007 May-Jun;12(3):034036.
PMID: 17614744 [PubMed - in process]


This website is certified by Health On the Net Foundation. Click to verify. HOME | DATABASE | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | SiteMap | Stem Cells | Wikipedia | WHO Classification | CURRENT NEURO-ONCOLOGY 
bottom